Work

Real-life use of bronchodilators and inhaled corticosteroids in cystic fibrosis and non-CF bronchiectasis, Do guidelines matter?

Year: 2025

Type: article

Abstract: Bronchiectasis is a pulmonary condition defined by an abnormal dilation of the bronchial lumen. Patients will typically have a frequent cough, often productive of sputum with purulent components, and there may be episodes of acute worsening of symptoms called pulmonary exacerbations [1]. It is a heterogeneous condition known to be associated with or caused by numerous etiologies, both pulmonary and extrapulmonary, including cystic fibrosis (CF) [2]. Bronchiectasis is often accompanied by impaired mucociliary clearance creating an environment susceptible to persistent infection and inflammation, inferred by the imaging appearance of thickening of the bronchial wall and/or mucus plugs [3].

Source: Journal of Cystic Fibrosis

DOI: 10.1016/j.jcf.2025.12.013

Authors: Miguel Angel Martinez Garcia, Patrick A Flume

Institutions: Hospital Universitari i Politècnic La Fe, Medical University of South Carolina

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,370